Guided Therapeutics (GTHP) Stock Chart & Stock Price History $0.19 -0.01 (-5.00%) As of 03:03 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock Guided Therapeutics Stock Price Performance The Guided Therapeutics (GTHP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 72.73%, with a year-to-date return of 26.67%. In the past month, the stock has increased 80.95%, reflecting recent market activity. As of the latest close, Guided Therapeutics traded at $0.20 with a market cap of $15.78 million and volume of 139,454 shares. Receive GTHP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+14.05%1 Month Performance+80.95%3 Month Performance+113.48%Year-To-Date Performance+26.67%1 Year Performance+72.73% GTHP Stock Chart for Thursday, June, 12, 2025 GTHP Chart by TradingView Guided Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/12/2025$0.20$0.19-5.00%$0.20$0.1915,800 shs$14.99 million06/11/2025$0.18$0.20+14.29%$0.20$0.18139,454 shs$15.78 million06/10/2025$0.18$0.18$0.18$0.1515,826 shs$13.81 million06/09/2025$0.17$0.18+5.04%$0.18$0.1419,803 shs$13.81 million06/06/2025$0.14$0.17+17.74%$0.17$0.148,803 shs$13.15 million06/05/2025$0.13$0.14+7.60%$0.14$0.132,902 shs$11.17 million06/04/2025$0.14$0.13-6.07%$0.13$0.13301 shs$10.38 million06/03/2025$0.14$0.14$0.14$0.146,240 shs$11.05 million06/02/2025$0.14$0.14$0.14$0.146,240 shs$11.05 million05/30/2025$0.14$0.14$0.14$0.125,559 shs$11.05 million Get the Latest News and Ratings for GTHP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025$0.14$0.14$0.14$0.125,559 shs$11.05 million05/28/2025$0.14$0.14$0.14$0.093,265 shs$11.05 million05/27/2025$0.14$0.14$0.14$0.097,334 shs$11.05 million05/26/2025$0.14$0.14$0.14$0.122,680 shs$11.05 million05/23/2025$0.13$0.14+12.00%$0.14$0.122,680 shs$11.05 million05/22/2025$0.13$0.13$0.13$0.131 shs$9.86 million05/21/2025$0.13$0.13$0.13$0.097,578 shs$9.86 million05/20/2025$0.13$0.13$0.13$0.097,578 shs$9.86 million05/19/2025$0.13$0.13$0.13$0.131,602 shs$9.86 million05/16/2025$0.09$0.13+38.89%$0.14$0.1014,476 shs$9.86 million05/15/2025$0.10$0.09-10.00%$0.09$0.0917,409 shs$7.10 million05/14/2025$0.10$0.10$0.10$0.109,002 shs$7.89 million05/13/2025$0.11$0.10-4.76%$0.10$0.103,140 shs$7.89 million05/12/2025$0.10$0.11+5.00%$0.11$0.0928,802 shs$8.29 million Related Companies Positron Stock Chart Spectral AI Stock Chart Alpha Pro Tech Stock Chart Modular Medical Stock Chart Daxor Stock Chart electroCore Stock Chart Safe Pro Group Inc. Common Stock Stock Chart United Health Products Stock Chart Precision Optics Stock Chart Nephros Stock Chart Receive GTHP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:GTHP) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored50-year legend: Here’s exact day stocks will crashGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guided Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guided Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GTHP Stock Free GTHP Stock Alerts